Younger age significantly increases the risk of recurrence following primary ventral hernia repair. 35.6% of patients aged 20-29 experience recurrence, a 15% higher rate compared to those aged 50-59. Overall recurrence prevalence declines with patient age; this trend holds across various subgroup analyses. Consider patient age in preoperative risk counseling to better inform surgical decisions. […]
Category: General Surgery
Standardizing Day 1 Discharge After Minimally Invasive Colon Surgery
Implementing a day-1 discharge pathway for minimally invasive colon surgery is safe and effective. Discharge rates jumped from 4.6% to 65.0% after pathway adoption (p < 0.001). Median hospital stay shrank from 3.0 to 1.0 days (p < 0.001), with no increase in readmissions (p = 0.43) or severe complications (p = 0.91). Tailor discharge […]
Radiotherapy Duration in Total Neoadjuvant Therapy for Rectal Cancer
Short versus long course radiation in total neoadjuvant therapy for locally advanced rectal cancer yields similar overall survival outcomes. Overall survival at 48 months is comparable between long course (86.2%) and short course (13.8%) radiation (p = 0.397). Long course radiotherapy shows higher nodal downstaging rates (66.5% vs 62.7%, p = 0.023). Consider both regimens […]
Laparoscopic TEP Biopsy for Pelvic Lymphadenopathy Delivers High Success
The laparoscopic totally extra-peritoneal (TEP) approach for suprainguinal lymph node biopsies shows high efficacy and safety. 94% of patients achieved a definitive diagnosis from the excised tissue. Median operative time was 51.5 minutes, with a median hospital stay of just 1 day. Surgeons can confidently consider this technique for lymphadenopathy cases, reducing recovery time and […]
Impact of Corporatization on Surgical Team Dynamics
Surgeons must recognize that corporatization is compromising team cohesion and clinical performance. For-profit ownership accounts for 23.7% of U.S. healthcare market share in 2023, affecting surgical autonomy. Pressure for productivity is linked to increased burnout, higher error rates, and lower patient satisfaction. Supporting structures that empower surgeons and maintain accountability could enhance outcomes and team […]
Understanding Non-Receipt of Treatment in Pancreatic Cancer
Non-receipt of guideline-concordant treatment in pancreatic cancer is linked to worse outcomes and distinct patient patterns. 32.4% of patients in a study cohort did not receive guideline-concordant treatment. Key factors include socioeconomic status, access to care, and patient vulnerability at first contact. Addressing these factors may improve treatment access and outcomes. Areas with higher deprivation […]
Long-Term Mortality Risk in Early Onset Solid Cancer Survivors
Survivors of early onset solid cancers face high late mortality risks, significantly affecting surgical outcomes. At 40 years post-diagnosis, cumulative all-cause mortality is 50%. Survivors have an all-cause mortality rate 77% higher than the general population. Non-cancer health-related causes eventually lead to more deaths than cancer progression. Surgeons should be aware of these long-term risks […]
Assessing Risks of Postpancreatectomy Hemorrhage
Surgeons need to know that bile leaks and Klebsiella pneumoniae infections are major predictors of severe postpancreatectomy hemorrhage in patients with postoperative pancreatic fistulas. Postpancreatectomy hemorrhage occurred in 7.8% of patients, with grade b/c complications in 5.2%. The pancreaticojejunal anastomosis was the most frequent bleeding source (15.6%), followed by branches of the superior mesenteric artery […]
Increase Colorectal Cancer Screening During Anorectal Visits
Missed opportunities exist during benign anorectal visits to boost colorectal cancer screening for patients under 50. Only 60.5% of adults aged 45-49 had a colonoscopy in the last decade. 69% completed the colonoscopy when recommended, versus 0% without a recommendation. Surgeons should leverage these visits to encourage screening, significantly impacting early detection and patient outcomes. […]
Waiting Times for Cancer Surgery Rising, Impacting Outcomes
Patients are experiencing longer delays for definitive cancer surgery, with median wait times increasing across multiple malignancies since 2012. Median wait times from diagnosis to first surgery rose for breast cancer from 34 to 45 days, and for lung cancer from 41 to 53 days. Delays are significantly longer at academic centers and for patients […]